PART01 Conference Introduction
From May 28th to 29th, Diagmand2025 will be held at Suzhou Shishan International Convention Center. The conference will set up four sub-forums, covering the entire technology chain of chemiluminescence, specific proteins, flow cytometry, and immunochromatography. More than 60 industry leaders will share practical topics from raw material screening, process design, production quality control, scenario implementation, and cutting-edge applications.
Beijing Qihengxing Biotechnology will bring its star products (blood direct PCR premix, magnetic bead-based nucleic acid extraction series products, probe-based qPCR Mix series products, the most comprehensive domestic Qubit reagents, etc.) to participate in this exhibition and give wonderful speeches. At the same time, we have prepared luxurious gifts for everyone. Welcome to visit C01 Exchange at the booth.
time: May 28-29, 2025
Place: Suzhou Shishan International Convention Center
PART02 Speech Information
Speech Topic : The bottlenecks and breakthroughs in molecular reagent development from the perspective of raw material development
Speech time: May 29 9:30-10:00
Speech Location: Conference Room 1 (Innovative PCR Technology and Application Forum)
PART03 Booth C01
PART04 Meeting Agenda
May 28 (DAY1)
Forum topics: Molecular POCT/immunochromatography/nucleic acid mass spectrometry/clinical mass spectrometry/core raw materials for advanced molecular testing/chemiluminescence/gene sequencing/infectious disease quality control products/protein raw materials/out-of-hospital diagnosis/rapid detection of plant infectious diseases
May 29 (DAY2)
Forum topics: Innovative PCR technology and applications / flow cytometry / multiplex detection / AD diagnosis / freeze-drying technology / respiratory infectious disease diagnosis / biochemistry and specific proteins / gene sequencing / multi-omics technology / protein raw materials / IVD instrument automation and core components / international development and innovation of the IVD industry / IVD exports to Southeast Asia
PART05 Audience Registration
